Skip to content

Mutations of Glucocorticoid Receptor in Bilateral Adrenal Hyperplasia

Prevalence of Mutations of Glucocorticoid Receptors in Bilateral Adrenal Hyperplasia

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02810496
Acronym
MUTA-GR
Enrollment
150
Registered
2016-06-23
Start date
2012-04-02
Completion date
2016-12-31
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Glucocorticoid Resistance

Brief summary

As the investigators observed a case of glucocorticoid mutation revealed by incidentally discovered bilateral adrenal nodular hyperplasia, it was postulated that this molecular anormality could be more frequent than previously described. To validate this hypothesis, it was decided to study 150 multicenter consecutive patients, presenting with incidentally discovered bilateral adrenal masses without clinical signs of Cushing's disease. In all these patients GR gene will be studied, mutations will be detected and described, functional disturbance will be tested. Usual polymorphisms will be described. Correlation between clinical signs, hormonal and morphological abnormalities and presence or absence of GR mutations will be searched.

Interventions

GENETICblood collection for mutation characterization

Sponsors

CHU de Reims
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients more than 18 years of age * patients with bilateral adrenal masses

Exclusion criteria

* Refusing to participate in the study * Protected by law * Have obvious signs of Cushing's syndrome * No progressive neoplastic disease

Design outcomes

Primary

MeasureTime frame
frequency of mutationsDAY 0

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026